Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akorn Inc (AKRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,140,375
  • Shares Outstanding, K 124,560
  • Annual Sales, $ 1,117 M
  • Annual Income, $ 184,240 K
  • 36-Month Beta 1.14
  • Price/Sales 3.70
  • Price/Cash Flow 11.16
  • Price/Book 4.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.86 +1.07%
on 05/03/17
33.53 -0.95%
on 05/02/17
+0.03 (+0.09%)
since 04/26/17
3-Month
20.00 +66.05%
on 03/01/17
34.00 -2.32%
on 04/24/17
+11.93 (+56.06%)
since 02/24/17
52-Week
17.61 +88.59%
on 12/07/16
35.40 -6.19%
on 08/04/16
+3.46 (+11.63%)
since 05/26/16

Most Recent Stories

More News
Akorn Shares Up 53.3% Since SmarTrend's Buy Recommendation (AKRX)

SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 3 months, Akorn has returned 53.27% as of today's recent price of $33.23.

AKRX : 33.21 (-0.09%)
Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Akorn, Inc. - AKRX

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Akorn, Inc. ("Akorn"...

AKRX : 33.21 (-0.09%)
Akorn Up 52.9% Since SmarTrend Uptrend Call (AKRX)

SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 3 months, Akorn has returned 52.86% as of today's recent price of $33.14.

AKRX : 33.21 (-0.09%)
How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy

Pre-market today, Stock-Callers.com directs attention to Akorn Inc. (NASDAQ: AKRX), Collegium Pharmaceutical Inc. (NASDAQ: COLL), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), and Diplomat Pharmacy Inc....

COLL : 8.80 (-3.83%)
MNTA : 14.75 (-1.67%)
AKRX : 33.21 (-0.09%)
DPLO : 17.48 (-0.68%)
Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.24% Sell Off

Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $32.86 to a high of $33.35. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $33.23 on volume...

AKRX : 33.21 (-0.09%)
Uptrend Call Working As Akorn Stock Rises 54.5% (AKRX)

SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 3 months, Akorn has returned 54.50% as of today's recent price of $33.49.

AKRX : 33.21 (-0.09%)
Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts Holding Company, China Unicom (Hong Kong) Limited, and Global Eagle Entertainment Inc.

AdvancePierre Foods Holdings, Inc. (APFH)

CHU : 14.34 (+0.28%)
CHUFF : 1.1300 (-0.88%)
ESRX : 59.76 (-0.55%)
ENT : 3.25 (+1.88%)
ASPS : 21.16 (+2.37%)
AKRX : 33.21 (-0.09%)
AMMA : 1.26 (+1.61%)
TACO : 12.90 (-0.15%)
TSN : 58.34 (+0.41%)
APFH : 40.31 (+0.15%)
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Akorn, Inc. and Encourages Investors to Contact the Firm for Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

AKRX : 33.21 (-0.09%)
Akorn Shares Up 52.1% Since SmarTrend's Buy Recommendation (AKRX)

SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 2 months, Akorn has returned 52.12% as of today's recent price of $32.98.

AKRX : 33.21 (-0.09%)
Harwood Feffer LLP Announces Investigation of Akorn, Inc.

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) concerning the proposed acquisition of the Company...

AKRX : 33.21 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers,...

See More

Support & Resistance

2nd Resistance Point 33.30
1st Resistance Point 33.26
Last Price 33.21
1st Support Level 33.17
2nd Support Level 33.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.